BGLC — BioNexus Gene Lab Corp.

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Chart, dilution, float and news for BGLC in the TickerWise workspace.

BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

Company profile

• Sector: Healthcare
• Industry: Medical - Diagnostics & Research
• Country: MY
• Exchange: NASDAQ Capital Market
• Employees: 30
• Website: https://www.bionexusgenelab.com

Latest SEC filings for BGLC

• 2026-05-1510-Q
• 2026-04-1410-K
• 2026-03-31NT 10-K
• 2026-03-178-K
• 2026-02-238-K
• 2026-02-038-K
• 2025-12-308-K
• 2025-12-238-K
• 2025-12-028-K
• 2025-11-1410-Q

Latest BGLC news

• 2026-10-07BioNexus to Build AI Applications for Malaysian Healthcare Under Exclusive CogniAI Licence Read article
• 2026-10-05RYET to Enter Malaysian Healthcare Through Exclusive Cogni AI License to BioNexus Gene Lab Read article

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Educational tool only — not investment advice.